




Searching News Database: ella
HSMN NewsFeed - 12 Dec 2024
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
HSMN NewsFeed - 9 Oct 2023
Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial
Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial
HSMN NewsFeed - 16 Aug 2022
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
HSMN NewsFeed - 16 Jun 2021
KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline
KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline
HSMN NewsFeed - 25 May 2021
Boston Scientific Completes CE Mark for EXALT(TM) Model B Single-Use Bronchoscope
Boston Scientific Completes CE Mark for EXALT(TM) Model B Single-Use Bronchoscope
HSMN NewsFeed - 11 Mar 2021
Qardio Announces FDA Clearance for QardioCore, a self-fit continuous ambulatory ECG to view and annotate ECG
Qardio Announces FDA Clearance for QardioCore, a self-fit continuous ambulatory ECG to view and annotate ECG
HSMN NewsFeed - 20 Jan 2021
Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip(TM) Device
Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip(TM) Device
HSMN NewsFeed - 19 Nov 2020
Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes
Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes
HSMN NewsFeed - 22 Jun 2020
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
HSMN NewsFeed - 14 Oct 2019
Magnetic Insight Announces the Appointment of David Panzarella as Chief Commercial Officer
Magnetic Insight Announces the Appointment of David Panzarella as Chief Commercial Officer
HSMN NewsFeed - 13 Jun 2019
Elekta Increases Focus on Digitization - Hires Sukhveer Singh to Drive Elekta Digital strategy
Elekta Increases Focus on Digitization - Hires Sukhveer Singh to Drive Elekta Digital strategy
HSMN NewsFeed - 27 Mar 2019
FDA Clears the Cervella Cranial Electrotherapy Stimulator for Treatment of Anxiety, Insomnia, and Depression
FDA Clears the Cervella Cranial Electrotherapy Stimulator for Treatment of Anxiety, Insomnia, and Depression
HSMN NewsFeed - 18 Mar 2019
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
HSMN NewsFeed - 5 Dec 2018
Olympus Spiration(R) Valve System Is FDA Approved for the Endobronchial Treatment of Emphysema
Olympus Spiration(R) Valve System Is FDA Approved for the Endobronchial Treatment of Emphysema
HSMN NewsFeed - 23 Oct 2018
BioGX Launches 5 new CE Mark IVD Tests, Expands Sexual Health Panels on the BD MAX(TM)
BioGX Launches 5 new CE Mark IVD Tests, Expands Sexual Health Panels on the BD MAX(TM)
HSMN NewsFeed - 14 Sep 2018
Endotronix Raises $45 Million in Series D Financing for the Treatment of Heart Failure
Endotronix Raises $45 Million in Series D Financing for the Treatment of Heart Failure
HSMN NewsFeed - 21 May 2018
CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
HSMN NewsFeed - 2 May 2018
Nobles Medical Launches Sales of its NobleStitch(TM) EL for PFO Closure in Spain
Nobles Medical Launches Sales of its NobleStitch(TM) EL for PFO Closure in Spain
HSMN NewsFeed - 13 Feb 2018
Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
HSMN NewsFeed - 15 Jan 2018
BD and Check-Points Receive CE Mark for Next-generation Resistant Bacteria Screening Test
BD and Check-Points Receive CE Mark for Next-generation Resistant Bacteria Screening Test
HSMN NewsFeed - 9 Nov 2017
Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure
Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure
HSMN NewsFeed - 18 Sep 2017
Kaleido Biosciences Announces Appointment of Mike Bonney as CEO and Completion of Additional Fundraising
Kaleido Biosciences Announces Appointment of Mike Bonney as CEO and Completion of Additional Fundraising
HSMN NewsFeed - 11 Sep 2017
Zimmer Biomet Announces Global Launch of the Persona(R) Partial Knee System
Zimmer Biomet Announces Global Launch of the Persona(R) Partial Knee System
HSMN NewsFeed - 11 Jul 2017
Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
HSMN NewsFeed - 19 May 2017
Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar
Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar
HSMN NewsFeed - 18 Apr 2017
Cardinal Health to Acquire Leading Patient Product Portfolio from Medtronic for $6.1 Billion
Cardinal Health to Acquire Leading Patient Product Portfolio from Medtronic for $6.1 Billion
HSMN NewsFeed - 11 Apr 2017
Intellijoint Surgical(R) Completes One Thousand Total Hip Replacement Procedures with intellijoint HIP(R)
Intellijoint Surgical(R) Completes One Thousand Total Hip Replacement Procedures with intellijoint HIP(R)
HSMN NewsFeed - 30 Mar 2017
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
HSMN NewsFeed - 6 Mar 2017
Izun Pharmaceuticals Announces Approval of Curasite(TM) Hydrogel Wound Care Product by FDA
Izun Pharmaceuticals Announces Approval of Curasite(TM) Hydrogel Wound Care Product by FDA
HSMN NewsFeed - 9 Aug 2016
Alere Achieves IVD CE Mark for its Alere(TM) Reader Lateral Flow Assay Analyzer
Alere Achieves IVD CE Mark for its Alere(TM) Reader Lateral Flow Assay Analyzer
HSMN NewsFeed - 20 Jul 2016
Juniper Pharmaceuticals Appoints Alicia Secor President and Chief Executive Officer
Juniper Pharmaceuticals Appoints Alicia Secor President and Chief Executive Officer
HSMN NewsFeed - 21 Jun 2016
Lumos Pharma Appoints Carol A. Dutch As Senior Director, Patient Engagement
Lumos Pharma Appoints Carol A. Dutch As Senior Director, Patient Engagement
HSMN NewsFeed - 2 Jun 2016
Juniper Pharmaceuticals Announces Planned Retirement of CEO Frank Condella
Juniper Pharmaceuticals Announces Planned Retirement of CEO Frank Condella
HSMN NewsFeed - 31 May 2016
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
HSMN NewsFeed - 16 May 2016
Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.
Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.
HSMN NewsFeed - 29 Mar 2016
Cairn Diagnostics Launches FDA-Approved Spirulina Gastric Emptying Breath Test for Gastroparesis
Cairn Diagnostics Launches FDA-Approved Spirulina Gastric Emptying Breath Test for Gastroparesis
HSMN NewsFeed - 16 Feb 2016
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
HSMN NewsFeed - 19 Jan 2016
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
HSMN NewsFeed - 27 Oct 2015
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
HSMN NewsFeed - 1 Oct 2015
AcelRx Pharmaceuticals Appoints Gina Ford as Vice President Commercial Strategy
AcelRx Pharmaceuticals Appoints Gina Ford as Vice President Commercial Strategy
HSMN NewsFeed - 17 Aug 2015
GE Healthcare First to Receive FDA Clearance for Low Dose CT Lung Cancer Screening
GE Healthcare First to Receive FDA Clearance for Low Dose CT Lung Cancer Screening
HSMN NewsFeed - 10 Aug 2015
Helix Medical and MedVenture Technology Announce Name Change to Freudenberg Medical
Helix Medical and MedVenture Technology Announce Name Change to Freudenberg Medical
HSMN NewsFeed - 27 May 2015
Zafgen Appoints Global Head of Medical Affairs and Global Head of Regulatory
Zafgen Appoints Global Head of Medical Affairs and Global Head of Regulatory
HSMN NewsFeed - 19 Feb 2015
Merganser Biotech Inc. Raises $28 Million in a Series A Financing to Develop Hepcidin Mimetic Peptides
Merganser Biotech Inc. Raises $28 Million in a Series A Financing to Develop Hepcidin Mimetic Peptides
HSMN NewsFeed - 4 Feb 2015
Concert Pharmaceuticals Announces Appointment of James V. Cassella as Chief Development Officer
Concert Pharmaceuticals Announces Appointment of James V. Cassella as Chief Development Officer
HSMN NewsFeed - 13 Jan 2015
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
HSMN NewsFeed - 3 Oct 2014
Salix Pharmaceuticals and Cosmo Technologies Announce Termination of Merger Agreement
Salix Pharmaceuticals and Cosmo Technologies Announce Termination of Merger Agreement
HSMN NewsFeed - 29 Sep 2014
Lumara Health(TM) to be Acquired in Two Separate Transactions for up to $1.107 Billion
Lumara Health(TM) to be Acquired in Two Separate Transactions for up to $1.107 Billion
HSMN NewsFeed - 14 Aug 2014
Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals
Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals
HSMN NewsFeed - 17 Apr 2014
Gamma Medica Creates Strategic Advisory Board Chaired by Veteran Health Technology Executive Robert Cascella
Gamma Medica Creates Strategic Advisory Board Chaired by Veteran Health Technology Executive Robert Cascella
HSMN NewsFeed - 19 Mar 2014
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc
HSMN NewsFeed - 21 Feb 2014
GC Aesthetics raises $60M to Fund Global Growth and New Product Development
GC Aesthetics raises $60M to Fund Global Growth and New Product Development
HSMN NewsFeed - 5 Feb 2014
Pluristem Strengthens Executive Team; Announces Senior Executive Appointments
Pluristem Strengthens Executive Team; Announces Senior Executive Appointments
HSMN NewsFeed - 31 Jan 2014
Acella Pharmaceuticals, LLC, Announces Approval and Launch of Loutrex Topical Cream
Acella Pharmaceuticals, LLC, Announces Approval and Launch of Loutrex Topical Cream
HSMN NewsFeed - 30 Dec 2013
FDA Approves SALMONELEX(TM) Against Salmonella as New Food Processing Aid
FDA Approves SALMONELEX(TM) Against Salmonella as New Food Processing Aid
HSMN NewsFeed - 2 Dec 2013
InspireMD Appoints Rick Olson as Vice President of Global Sales Operations
InspireMD Appoints Rick Olson as Vice President of Global Sales Operations
HSMN NewsFeed - 8 Nov 2013
EMD Serono Announces Appointment of Paris Panayiotopoulos as President and Managing Director
EMD Serono Announces Appointment of Paris Panayiotopoulos as President and Managing Director
HSMN NewsFeed - 18 Oct 2013
Cimzia(R) (Certolizumab Pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis
Cimzia(R) (Certolizumab Pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis
HSMN NewsFeed - 24 Sep 2013
Forest Laboratories, Inc. Files Lawsuits against Several Companies for Infringement of Savella(R) Patents
Forest Laboratories, Inc. Files Lawsuits against Several Companies for Infringement of Savella(R) Patents
HSMN NewsFeed - 3 Sep 2013
Amakem Appoints Jean Marie Stassen as Vice President, Research and Development
Amakem Appoints Jean Marie Stassen as Vice President, Research and Development
HSMN NewsFeed - 28 Aug 2013
Study Demonstrates Glysure System's Ability to Accurately Measure Blood Glucose Levels in the ICU
Study Demonstrates Glysure System's Ability to Accurately Measure Blood Glucose Levels in the ICU
HSMN NewsFeed - 26 Jul 2013
Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
HSMN NewsFeed - 25 Jun 2013
BioFire Receives FDA Clearance for the FilmArray(R) Blood Culture Identification Panel
BioFire Receives FDA Clearance for the FilmArray(R) Blood Culture Identification Panel
HSMN NewsFeed - 25 Mar 2013
Angiotech announces sale of Interventional Products Business to Argon Medical Devices, Inc.
Angiotech announces sale of Interventional Products Business to Argon Medical Devices, Inc.
HSMN NewsFeed - 14 Mar 2013
Spectrum Pharmaceuticals Gains Rights to Pivotal-Stage Captisol-Enabled(R) Melphalan
Spectrum Pharmaceuticals Gains Rights to Pivotal-Stage Captisol-Enabled(R) Melphalan
HSMN NewsFeed - 21 Feb 2013
Alexza Receives Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
Alexza Receives Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
HSMN NewsFeed - 22 Oct 2012
Cappella Medical Announces Excellent Long Term Follow-Up Results for Its Sideguard(R) Technology at TCT 2012
Cappella Medical Announces Excellent Long Term Follow-Up Results for Its Sideguard(R) Technology at TCT 2012
HSMN NewsFeed - 17 Jul 2012
Biodesix Appoints Vice President of Clinical Development & Medical Affairs
Biodesix Appoints Vice President of Clinical Development & Medical Affairs
HSMN NewsFeed - 15 May 2012
Cappella Medical to Share Long Term Clinical Benefits of its Sideguard(R) Technology at EuroPCR 2012
Cappella Medical to Share Long Term Clinical Benefits of its Sideguard(R) Technology at EuroPCR 2012
HSMN NewsFeed - 2 May 2012
Acella Pharmaceuticals, LLC, Announces Approval of Generic Gabapentin Oral Solution
Acella Pharmaceuticals, LLC, Announces Approval of Generic Gabapentin Oral Solution
HSMN NewsFeed - 12 Apr 2012
New BIOTRONIK ICD and CRT-D Series Gives Patients First-Ever Access to MR Scans
New BIOTRONIK ICD and CRT-D Series Gives Patients First-Ever Access to MR Scans
HSMN NewsFeed - 10 Apr 2012
Santarus Appoints Alessandro E. Della Chà and Matthew W. Strobeck to Board of Directors
Santarus Appoints Alessandro E. Della Chà and Matthew W. Strobeck to Board of Directors
HSMN NewsFeed - 6 Mar 2012
Islet Sciences Names Dr. George J. Todaro and Dr. Jerry L. Nader to Board of Directors
Islet Sciences Names Dr. George J. Todaro and Dr. Jerry L. Nader to Board of Directors
HSMN NewsFeed - 6 Dec 2011
Amgen and FDA Agree to Modify Nplate(R) (Romiplostim) Risk Evaluation and Mitigation Strategy
Amgen and FDA Agree to Modify Nplate(R) (Romiplostim) Risk Evaluation and Mitigation Strategy
HSMN NewsFeed - 6 Sep 2011
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
HSMN NewsFeed - 24 May 2011
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
HSMN NewsFeed - 23 May 2011
Elixir Medical Receives CE Mark for DESyne(TM) Novolimus Eluting Coronary Stent System
Elixir Medical Receives CE Mark for DESyne(TM) Novolimus Eluting Coronary Stent System
HSMN NewsFeed - 17 May 2011
Cappella Medical to Share Data Documenting Benefits of Full Ostial Protection at EuroPCR 2011
Cappella Medical to Share Data Documenting Benefits of Full Ostial Protection at EuroPCR 2011
HSMN NewsFeed - 10 May 2011
Columbia Laboratories Appoints Kip Martin as Vice President, Business Development
Columbia Laboratories Appoints Kip Martin as Vice President, Business Development
HSMN NewsFeed - 5 May 2011
Boston Scientific Offers New CRT-D Warranty Program Covering Phrenic Nerve Stimulation
Boston Scientific Offers New CRT-D Warranty Program Covering Phrenic Nerve Stimulation
HSMN NewsFeed - 27 Apr 2011
BIOTRONIK Receives FDA Approval for Expansion of the Premium Evia Pacemaker Portfolio
BIOTRONIK Receives FDA Approval for Expansion of the Premium Evia Pacemaker Portfolio
HSMN NewsFeed - 15 Apr 2011
FDA Approves ACTEMRA(R) (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
FDA Approves ACTEMRA(R) (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
HSMN NewsFeed - 5 Apr 2011
Cappella Medical Announces Senior Management Changes as it Continues to Grow
Cappella Medical Announces Senior Management Changes as it Continues to Grow
HSMN NewsFeed - 24 Mar 2011
FDA Expands Indication for ZOSTAVAX(R), Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59
FDA Expands Indication for ZOSTAVAX(R), Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59
HSMN NewsFeed - 11 Feb 2011
Cappella Medical Announces New Sideguard(R) Clinical Data on Bifurcation Plaque Redistribution
Cappella Medical Announces New Sideguard(R) Clinical Data on Bifurcation Plaque Redistribution
HSMN NewsFeed - 31 Jan 2011
Cappella Medical Devices Announces First Enrolled Patients in Italian Sideguard(R) Study
Cappella Medical Devices Announces First Enrolled Patients in Italian Sideguard(R) Study
HSMN NewsFeed - 17 Jan 2011
AdvanDx Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)
AdvanDx Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)
HSMN NewsFeed - 21 Dec 2010
Ramius and Royalty Pharma Extend Tender Offer Until January 5, 2011 Pursuant to Definitive Merger Agreement
Ramius and Royalty Pharma Extend Tender Offer Until January 5, 2011 Pursuant to Definitive Merger Agreement
HSMN NewsFeed - 20 Dec 2010
Cappella Medical Systems Announces First Placements of its New Dual Marker Sideguard(R) System
Cappella Medical Systems Announces First Placements of its New Dual Marker Sideguard(R) System
HSMN NewsFeed - 13 Aug 2010
Watson Plans Q4 2010 ella(R) (ulipristal acetate) Emergency Contraceptive Launch
Watson Plans Q4 2010 ella(R) (ulipristal acetate) Emergency Contraceptive Launch
HSMN NewsFeed - 29 Jul 2010
FDA Advisory Committee Recommends US FDA Approval of Brilinta (Ticagrelor) for Acute Coronary Syndromes
FDA Advisory Committee Recommends US FDA Approval of Brilinta (Ticagrelor) for Acute Coronary Syndromes
HSMN NewsFeed - 1 Jun 2010
Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus
Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus
HSMN NewsFeed - 19 May 2010
Embrella Cardiovascular, Inc. Receives European CE Mark Approval for the Embrella Embolic Deflector Device
Embrella Cardiovascular, Inc. Receives European CE Mark Approval for the Embrella Embolic Deflector Device
HSMN NewsFeed - 5 May 2010
Frank C. Condella, Jr. Appointed President and Chief Executive Officer of Columbia Laboratories
Frank C. Condella, Jr. Appointed President and Chief Executive Officer of Columbia Laboratories
HSMN NewsFeed - 25 Jan 2010
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
HSMN NewsFeed - 21 Jan 2010
IsoRay Announces World's First Cesium-131 Colon Cancer Treatment at Cornell Medical Center
IsoRay Announces World's First Cesium-131 Colon Cancer Treatment at Cornell Medical Center
HSMN NewsFeed - 18 Jan 2010
AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
HSMN NewsFeed - 5 Jan 2010
Embrella Cardiovascular, Inc. Completes Successful First Clinical Experience
Embrella Cardiovascular, Inc. Completes Successful First Clinical Experience
HSMN NewsFeed - 25 Dec 2009
Masimo Expands its Irvine, California Corporate Headquarters to Accommodate Growth Projections
Masimo Expands its Irvine, California Corporate Headquarters to Accommodate Growth Projections
HSMN NewsFeed - 27 Oct 2009
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
HSMN NewsFeed - 11 Sep 2009
Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain
Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain
HSMN NewsFeed - 1 Jun 2009
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
HSMN NewsFeed - 20 Apr 2009
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
HSMN NewsFeed - 26 Mar 2009
Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
HSMN NewsFeed - 18 Mar 2009
Arobella Medical Announces European CE Mark Approval of Qoustic Wound Therapy System(TM)
Arobella Medical Announces European CE Mark Approval of Qoustic Wound Therapy System(TM)
HSMN NewsFeed - 11 Mar 2009
Journal of the American College of Cardiology Publishes PROTECT I Study Results for Abiomed Impella 2.5
Journal of the American College of Cardiology Publishes PROTECT I Study Results for Abiomed Impella 2.5
HSMN NewsFeed - 5 Mar 2009
Abiomed Appoints Michael Howley as Vice President and General Manager of Global Sales and Marketing
Abiomed Appoints Michael Howley as Vice President and General Manager of Global Sales and Marketing
HSMN NewsFeed - 5 Mar 2009
GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners
GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners
HSMN NewsFeed - 24 Feb 2009
Merck Serono and Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
Merck Serono and Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
HSMN NewsFeed - 19 Feb 2009
European Medicines Agency Recommends Suspension of Marketing Authorization for Raptiva(R)
European Medicines Agency Recommends Suspension of Marketing Authorization for Raptiva(R)
HSMN NewsFeed - 11 Feb 2009
JFK Memorial Hospital Announces Availability of Personalized Partial Knee Resurfacing System for Patients
JFK Memorial Hospital Announces Availability of Personalized Partial Knee Resurfacing System for Patients
HSMN NewsFeed - 10 Feb 2009
NMT Medical Appoints Board Member Frank Martin Interim President & Chief Executive Officer
NMT Medical Appoints Board Member Frank Martin Interim President & Chief Executive Officer
HSMN NewsFeed - 8 Jan 2009
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
HSMN NewsFeed - 22 Dec 2008
Pediatric Patient Treated Using RapidArc(TM) Radiotherapy Technology in Switzerland
Pediatric Patient Treated Using RapidArc(TM) Radiotherapy Technology in Switzerland
HSMN NewsFeed - 21 Sep 2008
Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
HSMN NewsFeed - 23 Jun 2008
Cambridge Heart Licenses Technology from Massachusetts Institute of Technology
Cambridge Heart Licenses Technology from Massachusetts Institute of Technology
HSMN NewsFeed - 10 Jun 2008
Merck Serono Strengthens its Prescription Medicines Portfolio in Latin America
Merck Serono Strengthens its Prescription Medicines Portfolio in Latin America
HSMN NewsFeed - 5 Jun 2008
Merck Serono Announces Initiation of Second Phase II/III Clinical Study of Atacicept in Lupus
Merck Serono Announces Initiation of Second Phase II/III Clinical Study of Atacicept in Lupus
HSMN NewsFeed - 21 May 2008
AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to Pfizer
AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to Pfizer
HSMN NewsFeed - 15 May 2008
CDC Recommends ZOSTAVAX(R), Merck's Shingles Vaccine, for All Appropriate Adults Aged 60 and Older
CDC Recommends ZOSTAVAX(R), Merck's Shingles Vaccine, for All Appropriate Adults Aged 60 and Older
HSMN NewsFeed - 21 Apr 2008
Premier Healthcare Alliance Adds New Members with $1.1 Billion in Purchasing Volume in 2007
Premier Healthcare Alliance Adds New Members with $1.1 Billion in Purchasing Volume in 2007
HSMN NewsFeed - 16 Apr 2008
Merck Announces Planned Investment of $50 Million in Research Center in the US
Merck Announces Planned Investment of $50 Million in Research Center in the US
HSMN NewsFeed - 28 Mar 2008
Abiomed Announces Update on 510(k) Clearance Process for Impella 2.5 Circulatory Support Device
Abiomed Announces Update on 510(k) Clearance Process for Impella 2.5 Circulatory Support Device
HSMN NewsFeed - 17 Mar 2008
Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs
Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs
HSMN NewsFeed - 7 Mar 2008
Embrella Cardiovascular, Inc. Hires Carol Burns as Vice President of Product & Business Development
Embrella Cardiovascular, Inc. Hires Carol Burns as Vice President of Product & Business Development
HSMN NewsFeed - 20 Feb 2008
Strategic Diagnostics Expands Executive Team with 26-Year Veteran from Agilent Technologies
Strategic Diagnostics Expands Executive Team with 26-Year Veteran from Agilent Technologies
HSMN NewsFeed - 6 Feb 2008
Safeguard Scientifics and New Venture Partners Co-Lead $7.7 Million Series A Financing for Alverix, Inc.
Safeguard Scientifics and New Venture Partners Co-Lead $7.7 Million Series A Financing for Alverix, Inc.
HSMN NewsFeed - 23 Jan 2008
Bausch & Lomb Names Gerald M. Ostrov Chairman and Chief Executive Officer
Bausch & Lomb Names Gerald M. Ostrov Chairman and Chief Executive Officer
HSMN NewsFeed - 17 Jan 2008
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
HSMN NewsFeed - 20 Nov 2007
A Magnetic Presence: Siemens New MRI Systems Pulling More Patients Toward the Benefits of MR Imaging
A Magnetic Presence: Siemens New MRI Systems Pulling More Patients Toward the Benefits of MR Imaging
HSMN NewsFeed - 22 Oct 2007
Elixir Medical Announces Positive Clinical Results for the Company's First Drug Eluting Coronary Stent
Elixir Medical Announces Positive Clinical Results for the Company's First Drug Eluting Coronary Stent
HSMN NewsFeed - 22 Oct 2007
AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. Announce Merger Agreement
AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. Announce Merger Agreement
HSMN NewsFeed - 25 Sep 2007
Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
HSMN NewsFeed - 18 Sep 2007
New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
HSMN NewsFeed - 30 Aug 2007
Abiomed Receives Conditional FDA Approval for Impella 2.5 Pivotal Study at up to 150 Hospitals
Abiomed Receives Conditional FDA Approval for Impella 2.5 Pivotal Study at up to 150 Hospitals
HSMN NewsFeed - 27 Aug 2007
BioLineRx In-Licenses Novel Drug for the Treatment of Acute Kidney Injury
BioLineRx In-Licenses Novel Drug for the Treatment of Acute Kidney Injury
HSMN NewsFeed - 2 Aug 2007
Vyteris Announces Appointment of Anthony J. Cherichella as Chief Financial Officer
Vyteris Announces Appointment of Anthony J. Cherichella as Chief Financial Officer
HSMN NewsFeed - 25 Jul 2007
A.T.S. Pharmaceuticals, A division of Auriga Laboratories Launches Xyralid(TM) LP Lotion
A.T.S. Pharmaceuticals, A division of Auriga Laboratories Launches Xyralid(TM) LP Lotion
HSMN NewsFeed - 19 Jul 2007
Bioresorbable Collagen Scaffold Placed inside the Heart Revolutionizes Treatment
Bioresorbable Collagen Scaffold Placed inside the Heart Revolutionizes Treatment
HSMN NewsFeed - 18 Jul 2007
Abiomed Announces Canadian Regulatory Approvals of Impella Circulatory Support Technologies
Abiomed Announces Canadian Regulatory Approvals of Impella Circulatory Support Technologies
HSMN NewsFeed - 21 Jun 2007
Trinity Biotech Announces Launch of Uni-Gold(TM) Legionella Urinary Antigen Test
Trinity Biotech Announces Launch of Uni-Gold(TM) Legionella Urinary Antigen Test
HSMN NewsFeed - 18 May 2007
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
HSMN NewsFeed - 23 Apr 2007
Abiomed Completes Enrollment of Pilot Clinical Trial for Impella 2.5 Circulatory Support System
Abiomed Completes Enrollment of Pilot Clinical Trial for Impella 2.5 Circulatory Support System
HSMN NewsFeed - 19 Apr 2007
Abiomed Announces Australian Regulatory Approval of Impella Circulatory Support Technologies
Abiomed Announces Australian Regulatory Approval of Impella Circulatory Support Technologies
HSMN NewsFeed - 19 Apr 2007
Merck KGaA and WHO Conclude Partnership to Control Schistosomiasis in Africa
Merck KGaA and WHO Conclude Partnership to Control Schistosomiasis in Africa
HSMN NewsFeed - 10 Apr 2007
FermaVir Pharmaceuticals, Inc. Signs Definitive Agreement to Be Acquired by Inhibitex, Inc.
FermaVir Pharmaceuticals, Inc. Signs Definitive Agreement to Be Acquired by Inhibitex, Inc.
HSMN NewsFeed - 12 Feb 2007
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
HSMN NewsFeed - 30 Jan 2007
Merck Serono Launches easypod(R), First Electronic Growth Hormone Injection Device
Merck Serono Launches easypod(R), First Electronic Growth Hormone Injection Device
HSMN NewsFeed - 23 Jan 2007
Barr's Subsidiary PLIVA Receives Approval for Generic ZITHROMAX(R) IV, 500 mg Vial
Barr's Subsidiary PLIVA Receives Approval for Generic ZITHROMAX(R) IV, 500 mg Vial
HSMN NewsFeed - 17 Jan 2007
Archemix and Merck KGaA to Collaborate on Aptamer-Based Cancer Therapeutics
Archemix and Merck KGaA to Collaborate on Aptamer-Based Cancer Therapeutics
HSMN NewsFeed - 16 Jan 2007
Merck Serono Announces Positive Results From Phase III Diet Study of Phenoptin for Phenylketonuria
Merck Serono Announces Positive Results From Phase III Diet Study of Phenoptin for Phenylketonuria
HSMN NewsFeed - 16 Jan 2007
Merck Serono Completes Patient Enrollment in CLARITY Phase III Pivotal Clinical Trial of Oral Cladribine
Merck Serono Completes Patient Enrollment in CLARITY Phase III Pivotal Clinical Trial of Oral Cladribine
HSMN NewsFeed - 8 Jan 2007
Abiomed Receives CE Mark for Intra-Aortic Balloon and iPulse Console System
Abiomed Receives CE Mark for Intra-Aortic Balloon and iPulse Console System
HSMN NewsFeed - 18 Dec 2006
First Patients Receive Transoma Medical's Implantable ECG Monitoring System
First Patients Receive Transoma Medical's Implantable ECG Monitoring System
HSMN NewsFeed - 7 Dec 2006
HRA Pharma Commences US Phase III Trial of Second-Generation Emergency Contraceptive
HRA Pharma Commences US Phase III Trial of Second-Generation Emergency Contraceptive
HSMN NewsFeed - 6 Dec 2006
New Bifurcation Stent System Provides Breakthrough in Treatment of Ostial-Bifurcated Lesions
New Bifurcation Stent System Provides Breakthrough in Treatment of Ostial-Bifurcated Lesions
HSMN NewsFeed - 4 Dec 2006
Janus Pharmaceuticals Inc. Announces Successful Phase II Study in Shingles
Janus Pharmaceuticals Inc. Announces Successful Phase II Study in Shingles
HSMN NewsFeed - 28 Nov 2006
Quinnova Pharmaceuticals, Inc. Completes $13.6 Million Series A Financing
Quinnova Pharmaceuticals, Inc. Completes $13.6 Million Series A Financing
HSMN NewsFeed - 13 Nov 2006
Abiomed Announces Five-Year, $16+ Million Impella and AB5000 Distribution Agreement with Medix Japan
Abiomed Announces Five-Year, $16+ Million Impella and AB5000 Distribution Agreement with Medix Japan
HSMN NewsFeed - 13 Nov 2006
Vion Pharmaceuticals Reaches Midpoint of Patient Accrual to Cloretazine(R) (VNP40101M) Phase III Trial
Vion Pharmaceuticals Reaches Midpoint of Patient Accrual to Cloretazine(R) (VNP40101M) Phase III Trial
HSMN NewsFeed - 27 Sep 2006
Cenix BioScience and Merck KGaA Sign Framework Agreement for RNAi-Based Drug Discovery
Cenix BioScience and Merck KGaA Sign Framework Agreement for RNAi-Based Drug Discovery
HSMN NewsFeed - 22 Sep 2006
Merck and Nicaragua Unveil New Rotavirus Vaccine Demonstration Project at Clinton Global Initiative
Merck and Nicaragua Unveil New Rotavirus Vaccine Demonstration Project at Clinton Global Initiative
HSMN NewsFeed - 21 Sep 2006
Cordis Corporation and Brivant Limited Sign Distribution Agreement for Three Interventional Products
Cordis Corporation and Brivant Limited Sign Distribution Agreement for Three Interventional Products
HSMN NewsFeed - 29 Jun 2006
sanofi-aventis Announces Update to Ketek(R) (Telithromycin) U.S. Prescribing Information
sanofi-aventis Announces Update to Ketek(R) (Telithromycin) U.S. Prescribing Information
HSMN NewsFeed - 27 Jun 2006
FDA Approves Abiomed's IDE for IMPELLA 5.0 Minimally Invasive Cardiac Support Systems
FDA Approves Abiomed's IDE for IMPELLA 5.0 Minimally Invasive Cardiac Support Systems
HSMN NewsFeed - 31 May 2006
Vion Pharmaceuticals Provides Update for Clinical and Preclinical Programs
Vion Pharmaceuticals Provides Update for Clinical and Preclinical Programs
HSMN NewsFeed - 26 May 2006
FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
HSMN NewsFeed - 22 May 2006
ABIOMED Announces French Regulatory Approval of the AB5000 Circulatory Support System
ABIOMED Announces French Regulatory Approval of the AB5000 Circulatory Support System
Additional items found! 202

Members Archive contains
202 additional stories matching:
ella
(Password required)
ella
(Password required)